Abstract
Chronic lymphocytic leukemia (CLL) is associated with physical dysfunction and low overall fitness that predicts poor survival following the commencement of treatment. However, it remains unknown whether higher fitness provides antioncogenic effects. We identified ten fit (CLL-FIT) and ten less fit (CLL-UNFIT) treatment-naïve CLL patients from 144 patients who completed a set of physical fitness and performance tests. Patient plasma was used to determine its effects on an
in vitro
5-day growth/viability of three B-cell cell lines (OSU-CLL, Daudi, and Farage). Plasma exosomal miRNA profiles, circulating lipids, lipoproteins, inflammation levels, and immune cell phenotypes were also assessed. CLL-FIT was associated with fewer viable OSU-CLL cells at Day 1 (
p
= 0.003), Day 4 (
p
= 0.001), and Day 5 (
p
= 0.009). No differences between the groups were observed for Daudi and Farage cells. Of 455 distinct exosomal miRNAs identified, 32 miRNAs were significantly different between the groups. Of these, 14 miRNAs had ≤−1 or ≥1 log2 fold differences. CLL-FIT patients had five exosomal miRNAs with lower expression and nine miRNAs with higher expression. CLL-FIT patients had higher HDL cholesterol, lower inflammation, and lower levels of triglyceride components (all
p
< 0.05). CLL-FIT patients had lower frequencies of low-differentiated NKG2+/CD158a/b
neg
(
p
= 0.015 and
p
= 0.014) and higher frequencies of NKG2A
neg
/CD158b+ mature NK cells (
p
= 0.047). The absolute number of lymphocytes, including CD19+/CD5+ CLL-cells, was similar between the groups (
p
= 0.359). Higher physical fitness in CLL patients is associated with altered CLL-like cell line growth
in vitro
and with altered circulating and cellular factors indicative of better immune functions and tumor control.